Courses | Page 12 | AUA University

Topic

Core Curriculum Related Education

Title	Category	Credit	Event date	List Price
AUA Guidelines on Early Detection of Prostate Cancer: Maximizing Benefits, Minimizing Harm Webcast (2025)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	Prostate cancer detection remains one of the most common and most controversial aspects of urologic practice. In addition to the complexities around screening and use of PSA, the role of other biomarkers, biopsy techniques such as transperineal biopsy, and MRI for targeted biopsy are evolving rapidly. This course is intended for urologists, advanced practice providers, and trainees interested in using the most evidence-based methods for optimizing detection of clinically important prostate cancers, while improving patient experience and minimizing complications.
Update Series (2025) Lesson 17: Urinary Retention and Benign Prostatic Hyperplasia in the Setting of Prostate Cancer		1.00 AMA PRA Category 1 Credit™ 1.00 Non-Physician Participation		$0.00	Audio Lessons - Listen on-the-go for Free!Did you know you can stream Update Series lessons from your favorite Podcast app (including Apple Podcast and Pocket Casts)?Add the Update Series Audio Lessons to Your Podcast Library Today!Please follow the download instructions to your preferred Podcast app, located below.
Update Series (2025) Lesson 18: Multidisciplinary Evaluation and Management of Pelvic Pain in Women		1.00 AMA PRA Category 1 Credit™ 1.00 Non-Physician Participation		$0.00	Audio Lessons - Listen on-the-go for Free!Did you know you can stream Update Series lessons from your favorite Podcast app (including Apple Podcast and Pocket Casts)?Add the Update Series Audio Lessons to Your Podcast Library Today!Please follow the download instructions to your preferred Podcast app, located below.
Update Series (2025) Lesson 19: Evaluation and Management of Recurrent Urethral Strictures After Urethroplasty		1.00 AMA PRA Category 1 Credit™ 1.00 Non-Physician Participation		$0.00	Audio Lessons - Listen on-the-go for Free!Did you know you can stream Update Series lessons from your favorite Podcast app (including Apple Podcast and Pocket Casts)?Add the Update Series Audio Lessons to Your Podcast Library Today!Please follow the download instructions to your preferred Podcast app, located below.
Update Series (2025) Lesson 20: Disorders of the Clitoris		1.00 AMA PRA Category 1 Credit™ 1.00 Non-Physician Participation		$0.00	Audio Lessons - Listen on-the-go for Free!Did you know you can stream Update Series lessons from your favorite Podcast app (including Apple Podcast and Pocket Casts)?Add the Update Series Audio Lessons to Your Podcast Library Today!Please follow the download instructions to your preferred Podcast app, located below.
Embracing Multi-Disciplinary Care for Advanced Prostate Cancer: A Case-Based Update Webcast (2025)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	This is an ongoing course on advanced prostate cancer at the annual AUA since 2012 and the changes over the last decade continue to be breathtaking! In the early years, it was all about metastatic castrate-resistant prostate cancer (mCRPC) with multiple new therapeutic advances starting in 2010 followed by novel oral antiandrogens and a focus on bone-targeted agents. Later, it expanded to cover hormone sensitive (HS) advanced disease due to the new data on chemotherapy and androgen synthesis inhibitors extending survival in new M1 patients.
Should I Order a PET Scan? Integrating Molecular Imaging Into Urologic Oncology Clinical Practice: Current Approaches and Future Opportunities...		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	This course is intended for practicing urologists, residents, fellows, and APPs interested in optimizing detection, staging, and follow-up of genitourinary malignancies through the use of molecular imaging opportunities. The attendee will explore current diagnostic imaging modalities, their performance characteristics, and imaging guidelines for cancer staging. This will lead into an introduction of novel molecular imaging tests and their clinical applications.
Chemotherapy and Immunotherapy for Urologists and Advanced Practice Providers (APPs) Webcast (2025)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	This course is taught by an interdisciplinary group of MDs and APPs and intended for a mixed audience of similar backgrounds. It describes in detail the treatment options for advanced and metastatic prostate, bladder, and kidney cancer, including non-muscle invasive bladder cancer. Up-to-date NCCN and AUA guidelines are utilized to guide the course. Because of the disease states and spaces that are the focus, most of the therapies that are taught are systemic, including cytotoxic chemotherapy, targeted biologic therapy, and immunotherapy, or more specifically check-point inhibitors.
Genetics and Genomics of Urological Cancers - Current Guidelines and Case-based Discussion to Guide Clinical Practice Webcast (2025)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	This case-based interactive course describes the role of germline genetics in urologic cancers and how the identification of an alteration may impact precision oncology. We will provide a concise and comprehensive review of hereditary cancer genetics, and discuss genetic risk assessment, diagnosis, and treatment for a range of hereditary kidney, adrenal, upper tract, and prostate cancer syndromes. We will review current NCCN and AUA guidelines for genetic evaluation of patients with kidney, adrenal, upper tract, and prostate cancers.
Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems Webcast (2025)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	This course will focus on specific topics discussed in the recent/amended AUA practice guidelines for non muscle-invasive bladder cancer (NMIBC) and detail strategies to manage common clinical predicaments involved in the management of these tumors. The course will include short didactic lectures by each of the faculty but will focus predominantly on case presentations highlighting common and often perplexing topics in NMIBC.
Highlights from AUA2025: Advances in NMIBC (2025)		1.00 AMA PRA Category 1 Credit™ 1.00 Non-Physician Participation		$0.00	Highlights from AUA2025: Advances in NMIBC will discuss the best in the latest advancements in Non-Muscle Invasive Bladder Cancer (NMIBC) from the AUA Annual Meeting!
The Evolving Landscape of Advanced Prostate Cancer Treatment: A Guidelines and Case-Based Discussion Webcast (2025)		4.00 AMA PRA Category 1 Credit™ 4.00 Non-Physician Participation		$0.00	This comprehensive, interactive course equips urologic professionals with the knowledge and skills needed to effectively manage patients with advanced prostate cancer. Through an in-depth exploration of guidelines, treatment modalities, and emerging therapies, participants will gain a thorough understanding of this complex disease and its evolving landscape. ACKNOWLEDGEMENTS:This educational activity is supported by independent educational grants from:
Integration of Biomarkers, MRI and PSMA PET Imaging Into the Management of Prostate Cancer Webcast (2025)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00
AUA Advanced Prostate Cancer Course Webcast (2025)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	This course will be focused on comprehensive AUA/SUO Guidelines on APC in the management and outcomes of men with biochemical recurrence, locally advanced, metastatic HSPC and CRPC. The course will include risk stratification, germline testing, PET imaging, the use of ADT in combination with novel androgen axis therapy and chemotherapy in men with newly diagnosed advanced and mHSPC. Early treatment intensification and evidenced based guidelines will be covered. The course will also cover non-metastatic CRPC, and treatment for mCRPC.
Incorporating Genomic Testing and Advanced Imaging for Prostate Cancer Into Your Practice Webcast (2025)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	There are multiple genomic tests and advanced imaging modalities (MRI, PSMA PET, etc) currently available for men to detect and risk stratify prostate cancer. The outcomes of these tests may lead to different detection strategies (observation, immediate biopsy, etc) and treatment decisions (active surveillance, surgery, radiation, adjuvant therapy, etc). We will also discuss germline testing as inherited mutations have considerable implications for screening, treatment, genetic counseling, and cascade testing of family members.

Pages